Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

被引:0
|
作者
Ciro Franzese
Veronica Vernier
Davide Franceschini
Tiziana Comito
Pierina Navarria
Elena Clerici
Maria Ausilia Teriaca
Maria Massaro
Luciana Di Cristina
Beatrice Marini
Carmela Galdieri
Pietro Mancosu
Stefano Tomatis
Marta Scorsetti
机构
[1] Humanitas University,Department of Biomedical Sciences
[2] IRCCS Humanitas Research Hospital,Department of Radiotherapy and Radiosurgery
关键词
Oligometastatic; SBRT; SABR; Stereotactic radiotherapy; Oligometastases; Multiple; Radiosurgery; Stereotactic ablative radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:10495 / 10503
页数:8
相关论文
共 50 条
  • [1] Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)
    Franzese, Ciro
    Vernier, Veronica
    Franceschini, Davide
    Comito, Tiziana
    Navarria, Pierina
    Clerici, Elena
    Teriaca, Maria Ausilia
    Massaro, Maria
    Di Cristina, Luciana
    Marini, Beatrice
    Galdieri, Carmela
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10495 - 10503
  • [2] Stereotactic ablative radiotherapy (SABR) for multiple oligometastases: efficacy and safety
    Franzese, C.
    Vernier, V.
    Franceschini, D.
    Comito, T.
    Navarria, P.
    Clerici, E.
    Teriaca, M. A.
    Massaro, M.
    Di Cristina, L.
    Marini, B.
    Galdieri, C.
    Mancosu, P.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1286 - S1287
  • [3] Stereotactic Ablative Radiotherapy (SABR) for Pulmonary Oligometastases and Oligoprogression
    Helou, Joelle
    Thibault, Isabelle
    Yeung, Latifa L.
    Poon, Ian
    Tjong, Michael
    Chiang, Andrew
    Jain, Suneil
    Soliman, Hany
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S636 - S636
  • [4] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR OLIGOMETASTASES: RISK STRATIFICATION USING POSITIONAL UNCERTAINTY
    Zhang, Tina
    Clark, Haley
    Thomas, Steven
    Olson, Robert
    Ma, Roy
    Schellenberg, Devin
    Palma, David
    Liu, Mitchell
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S85 - S86
  • [5] Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
    Siva, S.
    Bressel, M.
    Loi, S.
    Sandhu, S.
    Tran, B.
    Mooi, J.
    Lewin, J.
    Azad, A.
    Colyer, D.
    Shaw, M.
    Chander, S.
    Cuff, K.
    Wood, S.
    Lawrentschuk, N.
    Murphy, D.
    Pryor, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S248 - S248
  • [6] The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence
    Nicosia, L.
    Mazzola, R.
    Alongi, E.
    CLINICAL ONCOLOGY, 2022, 34 (07) : E320 - E321
  • [7] Stereotactic Ablative Radiotherapy (SABR) For Oligometastases: Risk Stratification Using Positional Uncertainty
    Zhang, T.
    Clark, H.
    Thomas, S.
    Olson, R. A.
    Ma, R.
    Schellenberg, D.
    Tyldesley, S.
    Palma, D. A.
    Liu, M. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E180 - E181
  • [8] Predictors of Local Control for Stereotactic Ablative Radiotherapy (SAbR) in Pulmonary Oligometastases from Gastrointestinal Malignancies
    Simoni, Nicola
    Micera, Renato
    Rossi, Gabriella
    Giri, Maria Grazia
    Pavarana, Michele
    Muraglia, Alessandro
    Cernusco, Nunzia Luna Valentina
    De Liguoro, Mario
    Guariglia, Stefania
    Cavedon, Carlo
    Milella, Michele
    Mazzarotto, Renzo
    ANTICANCER RESEARCH, 2020, 40 (10) : 5901 - 5907
  • [9] Radiomics for Early Detection of Recurrence in Patients Treated with Lung Stereotactic Ablative Radiotherapy (SABR)
    Kunkyab, T.
    Mou, B.
    Jirasek, A.
    Haston, C.
    Andrews, J.
    Thomas, S.
    Hyde, D.
    MEDICAL PHYSICS, 2020, 47 (06) : E436 - E436
  • [10] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
    Tekatli, H.
    Tetar, S.
    Warner, A.
    Palma, D.
    Verbakel, W.
    Nguyen, T.
    Spoelstra, F.
    Gaede, S.
    Slotman, B.
    Senan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143